journal cover

Allogeneic marrow transplantation for the treatment of leukaemia. A review

Scandinavian Journal of Haematology

Nov 1, 1975

T A AlvegårdR G Graw

PMID: 789

Abstract

22 HL-A antigen and mixed leukocyte culture-matched sibling bone marrow transplants were attempted in patients with acute leukaemia (at the National Cancer Institute) to define the toxicities of four different immunosuppressive regimens, the complications associated with warrow engraftm...read more

Mentioned in this Paper

Acute Leukemia
Graft Acceptance
Graft-vs-Host Disease
Bone Marrow
Red blood cells, blood product
Immunoglobulin Allotypes
Lymphocyte Culture Test, Mixed
Graft Vs Host Reaction
HLA Antigens
Acute Disease
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Lymphoid Neoplasms

Lymphoid neoplasms are derived from cells that frequently have features that recapitulate stages of normal b-, t-, and nk-cell differentiation and function. Lymphoid neoplasms include the following morphologic types: follicular center cell, lymphoblast (lymphocytic), immunoblast, plasma cell, and large granular lymphocyte (lgl). Here is the latest research on lymphoid neoplasms.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Immune Tolerance

Immune tolerance happens when the immune system is not responsive to a substance or organism and does not elicit an immune response. This is a normal physiological response for some antigens, especially when detecting self from non-self. This has been a potential area of therapy for some disorders. Here is the latest research on immune tolerance.

Hereditary Cancer Syndromes

Hereditary cancer syndromes comprise 5% of all cancers and have an increased risk of early onset and of multiple or bilateral malignancies. Here is the latest research on hereditary cancer syndromes.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Acute Lymphoblastic Leukemia

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Myelodysplastic Syndromes

Myelodysplastic syndromes are cancers in which immature blood cells in the bone marrow do not mature to become healthy blood cells. Discover the latest research on this cancer here.

© 2020 Meta ULC. All rights reserved

Allogeneic marrow transplantation for the treatment of leukaemia. A review

Scandinavian Journal of Haematology

Nov 1, 1975

T A AlvegårdR G Graw

PMID: 789

DOI:

Abstract

22 HL-A antigen and mixed leukocyte culture-matched sibling bone marrow transplants were attempted in patients with acute leukaemia (at the National Cancer Institute) to define the toxicities of four different immunosuppressive regimens, the complications associated with warrow engraftm...read more

Mentioned in this Paper

Acute Leukemia
Graft Acceptance
Graft-vs-Host Disease
Bone Marrow
Red blood cells, blood product
Immunoglobulin Allotypes
Lymphocyte Culture Test, Mixed
Graft Vs Host Reaction
HLA Antigens
Acute Disease

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/allogeneic-marrow-transplantation-for-the/789